BioInnovation Institute & Science Prize for Innovation
0 comments
by Amanda Clifford
Through the BioInnovation Institute Science Prize for Innovation, the editors of Science seek to recognize bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship...
Call for Applications: CBS Mentorship And Professional Development Program
0 comments
by Amanda Clifford
We are pleased to open the call for applications for the CBS Mentorship and Professional Development, a program specifically designed to connect professionals outside of academia with graduate students and postdoctoral fellows coming from the Canadian biomaterial s community...
14th Intl Symposium on Biodegradable Metals for Biomedical Applications
0 comments
by Neda Latifi
14th Intl Symposium on Biodegradable Metals for Applications on behalf of Professor Mantovani and the Quebec City Student Chapter Want to discover the next generation of bioresorbable metals aiming to bridge the gap between biomaterials and tissue engineering for pediatric, dental, orthopedic, vascular, cardiac, neurological applications, and more? The final program of the upcoming 14th Intl Symposium on Biodegradable Metals for Biomedical Applications is now online...
Women in the Business of Health Science Bootcamp
0 comments
by Neda Latifi
Dear CBS members on behalf of the OBIO WiHI Program , The OBIO Women in the Business of Health Science Bootcamp will take place between September 12 16, 2022, and is available at no cost to eligible applicants...
Liver cancer is the sixth most common cancer, and the second leading cause of cancer death1. The majority of liver cancer cases are hepatocellular carcinoma HCC ...
The clinical use of 7-ethyl-10-hydroxy-camptothecin SN-38 , the active metabolite of irinotecan, has been hampered because of its practical water-insolubility...
Neurodegenerative disease, stroke, and traumatic brain injury cause neuron death in the central nervous system, resulting in decreased motor, sensory, and or processing capability 1 ...
Breast cancer metastasis to bone is associated with poor patient prognosis as current non-specific therapeutics are administered systemically with deleterious side effects...
